Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration ; day:8 ; month:10 ; year:2024 ; pages:1-10
Eye ; (8.10.2024), 1-10
- Creator
-
Teo, Kelvin Yi Chong
Eldem, Bora
Joussen, Antonia
Koh, Adrian
Korobelnik, Jean-François
Li, Xiaoxin
Loewenstein, Anat
Lövestam-Adrian, Monica
Navarro, Rafael
Okada, Annabelle A.
Pearce, Ian
Rodríguez, Francisco
Wong, David
Wu, Lihteh
Zur, Dinah
Zarranz-Ventura, Javier
Mitchell, Paul
Chaudhary, Varun
Lanzetta, Paolo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41433-024-03370-0
- URN
-
urn:nbn:de:101:1-2412252119160.770796871007
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Teo, Kelvin Yi Chong
- Eldem, Bora
- Joussen, Antonia
- Koh, Adrian
- Korobelnik, Jean-François
- Li, Xiaoxin
- Loewenstein, Anat
- Lövestam-Adrian, Monica
- Navarro, Rafael
- Okada, Annabelle A.
- Pearce, Ian
- Rodríguez, Francisco
- Wong, David
- Wu, Lihteh
- Zur, Dinah
- Zarranz-Ventura, Javier
- Mitchell, Paul
- Chaudhary, Varun
- Lanzetta, Paolo
- SpringerLink (Online service)
Other Objects (12)
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Near-infrared reflectance imaging of neovascular age-related macular degeneration
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Efficacy and safety of abicipar in neovascular age-related macular degeneration
Vision protection therapy for prevention of neovascular age-related macular degeneration
Treatment of age-related neovascular macular degeneration: the patient’s perspective
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens
Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Near-infrared reflectance imaging of neovascular age-related macular degeneration
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Efficacy and safety of abicipar in neovascular age-related macular degeneration
Vision protection therapy for prevention of neovascular age-related macular degeneration
Treatment of age-related neovascular macular degeneration: the patient’s perspective
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens
Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Near-infrared reflectance imaging of neovascular age-related macular degeneration
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Efficacy and safety of abicipar in neovascular age-related macular degeneration
Vision protection therapy for prevention of neovascular age-related macular degeneration
Treatment of age-related neovascular macular degeneration: the patient’s perspective
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens
Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom